Search Results

The Biocodex Microbiota Foundation is announcing the 2024 open call for applications for its annual USA research grant.

PANTHERx Rare announces that it has been selected by Biocodex as their new exclusive U.S. pharmacy distribution partner for DIACOMIT® (stiripentol).

The Biocodex Microbiota Foundation is looking for academics and scientists in Canada to apply for a €25,000 research grant aimed at helping advance the study of the gut microbiome

Biocodex, Inc., a pharmaceutical company and manufacturer of DIACOMIT® (stiripentol), announced today that the U.S. Food and Drug Administration (FDA) has approved DIACOMIT for the treatment of seizures associated with Dravet syndrome in patients 6 months and older, weighing 15 lb or more, and taking clobazam.

The International Biocodex Microbiota Foundation has awarded its 2019 grant to Emily Balskus, Professor of Chemistry and Chemical Biology at Harvard University. “I am extremely honored to be chosen to receive this grant and am very grateful to the Biocodex Microbiota Foundation for supporting my research”, Prof. Balskus immediately reacted.

The Biocodex Microbiota Foundation (BMF), an organization founded by Biocodex and dedicated to inspiring scientific projects that explore the structure of microbiota, has announced that Dr. Tao Yang is the winner of the 2018 U.S. grant to research the role gut flora plays in the biochemical signaling events that occur between the gastrointestinal tract and the central nervous system.

North American Drs. Singh and Fernandez will use the grants from the Biocodex Research Foundation to field new research that examines dietary interactions with the gut microbiome in gastrointestinal disorders

4th Annual $50,000 Research Grant to be Awarded to US-Based Researcher for the Study of Gut Microbiota and Chronic Disease